Sex‐based differences in patients undergoing transseptal transcatheter mitral valve replacement: Closing the sex disparity gap

Abstract

Key Points In a nationwide registry of more than 2000 hospitalizations, the proportion of women undergoing transseptal transcatheter mitral valve replacement increased from 50.0% in 2015 to 60.2% in 2018. No significant differences were observed between sexes for complications, hospital length of stay, or in‐hospital mortality rate. Women had a higher 30‐day readmission rate and were more likely than men to be discharged to a skilled nursing facility.

Characteristics and Outcomes of Patients Ineligible for Transcatheter Mitral Valve Replacement

“…Compared to men, women tend to have more disproportionate MR, atrial fibrillation, MAC, and smaller ventricles, increasing the risk of screen failure based on anatomic complexity. 4 …”